Einstein launches SuperAgers.com to spotlight aging research
Website focuses on genetic links to healthy aging
2010-11-03
(Press-News.org) VIDEO:
SuperAgers.com website features aging research and video portraits of centenarians.
Click here for more information.
November 1, 2010 – (BRONX, NY) – Albert Einstein College of Medicine of Yeshiva University has launched SuperAgers.com, a new website that features the latest information on more than a decade of aging research at Einstein.
The SuperAgers.com website highlights the work of Nir Barzilai, M.D., director of the Institute for Aging Research and a team of researchers, coordinators and volunteers who, in 1998, began a study of healthy elderly between the ages of 95 and 112 years old. The group was enrolled in a study called the Longevity Genes Project. That research has grown into the LonGenity research study, which focuses on examining the genes of the very old. To date, the LonGenity research team has enrolled more than 500 centenarians and near-centenarians, and more than 700 of their children.
SuperAgers.com features video profiles of remarkable centenarians and near-centenarians who are taking part in the study, including 96-year-old Lilly Port who continues to travel the world; 104-year-old Irving Kahn, who works every day managing assets at his $700 million investment firm; 103-year-old Irma Daniel, who exercises and maintains an active social life; and 98-year-old Harold Laufman, a talented artist, musician and retired surgeon.
"The goal of the Longevity Genes Project is to understand how centenarians live so long," said Dr. Barzilai. "What is it in their genetic makeup that allows them to get to this age and remain healthy?"
The research is beginning to unlock the genetic code for longevity and identify the unique genotypes and phenotypes that protect against age-related diseases. Among the findings to date:
the identification of at least three genes thought to promote longevity;
evidence that longevity is highly likely to be inherited from generation to generation; and
the finding that those with exceptional longevity are more likely to have significantly elevated levels of HDL or "good" cholesterol.
The combination of these factors is believed to play a key role in the ability of these "super agers" to avoid cardiovascular disease, insulin resistance and high blood pressure.
As the study continues, Einstein researchers are hoping to better understand how protective or harmful genes are activated, or "turned on" or "turned off." This could lead to drug therapies that regulate gene expression and help people live longer, healthier lives by mimicking the beneficial effects of longevity genes.###
Visit SuperAgers.com for more information on the Longevity Genes Project, profiles of the "super agers," the latest updates on advances in aging-related research at Einstein and links to additional resources and research information.
The website is a project of the Einstein Department of Communications and Public Affairs and the Einstein Institute for Aging Research led by endocrinologist Dr. Nir Barzilai, who is director of the Nathan Shock Center of Excellence in the Basic Biology of Aging and the Ingeborg and Ira Leon Rennert Chair of Aging Research at Einstein.
About Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. During the 2009-2010 academic year, Einstein is home to 722 M.D. students, 243 Ph.D. students, 128 students in the combined M.D./Ph.D. program, and approximately 350 postdoctoral research fellows. The College of Medicine has 2,775 fulltime faculty members located on the main campus and at its clinical affiliates. In 2009, Einstein received more than $155 million in support from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Through its extensive affiliation network involving five medical centers in the Bronx, Manhattan and Long Island - which includes Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein - the College of Medicine runs one of the largest post-graduate medical training programs in the United States, offering approximately 150 residency programs to more than 2,500 physicians in training. For more information, please visit www.einstein.yu.edu
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-03
Washington, DC – Patients report decreased pain and improved breathing following treatment of their hilar tumors with robotic radiosurgery, but researchers say the therapy falls short of improving survival. Still, the study, conducted by researchers at Georgetown Lombardi Comprehensive Cancer Center and presented today at the annual meeting of the American College of Chest Physicians in Vancouver, BC, represents the first of its kind to document the use of radiosurgery for hilar tumors and presents a novel therapy option.
For the study, researchers reviewed the ...
2010-11-03
Fruit flies that grow obese after eating a diet loaded with fat could lead the way to the core elements of obesity, according to researchers who report their findings in the November issue of Cell Metabolism, a Cell Press publication.
The findings also get at obesity's origins. The demonstration that flies do become obese on a high-fat diet (HFD), much as humans do, indicates that the ability to become obese goes way, way back, the researchers say.
"The capacity for obesity is evolutionarily ancient," said Sean Oldham of the Sanford-Burnham Medical Research Institute. ...
2010-11-03
Researchers have identified a hormone produced and secreted by the liver as a previously unknown cause of insulin resistance. The findings, in the November issue of Cell Metabolism, a Cell Press publication, suggest a new target for the treatment of insulin resistance and type 2 diabetes, the researchers say.
"The current study sheds light on a previously underexplored function of the liver; the liver participates in the pathogenesis of insulin resistance through hormone secretion," said Hirofumi Misu of Kanazawa University Graduate School of Medical Science in Japan. ...
2010-11-03
In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less effective than oseltamivir monotherapy and not significantly more effective than zanamivir monotherapy. This key finding comes from a randomized, placebo-controlled trial— in adults presenting with influenza symptoms at general practices throughout France during the seasonal influenza epidemic in 2008-2009— carried out by Catherine Leport from the University of Paris, France, and colleagues, and reported in this week's PLoS Medicine.
In ...
2010-11-03
In this week's PLoS Medicine Magazine, Trisha Greenhalgh and Jill Russell from the Queen Mary University of London discuss the relative merits of "scientific" and "social practice" approaches to evaluation and argue that eHealth evaluation is in need of a paradigm shift. They critique the previous PLoS Medicine series on evaluating eHealth, published in late 2009.
INFORMATION:Funding: The ideas in this paper were developed during an independent evaluation of the UK Summary Care Record programme, funded by a research grant from the UK National Institute of Health Research ...
2010-11-03
David Henry discusses a recent research article in PLoS Medicine that suggests that relationships between doctors and drug companies are still too close. The research, by Geoffrey Spurling and colleagues, examined the relationship between exposure to promotional material from pharmaceutical companies and the quality, quantity, and cost of prescribing. David Henry's offers his Perspective in this week's PLoS Medicine Magazine.
INFORMATION:
Funding: The author received no specific funding for this article
Competing Interests: The author has declared that no competing ...
2010-11-03
BOSTON—The system for hospice admissions for patients with advanced dementia, which is a terminal illness, should be guided by patient and family preference for comfort, not estimated life expectancy, says a new study published in the Nov. 3 Journal of the American Medical Association by the Institute for Aging Research at Hebrew SeniorLife, an affiliate of Harvard Medical School.
Currently, patients requesting hospice services must be certified by their physician to have six months or less to live, and must sign a statement choosing comfort care services in lieu of curative ...
2010-11-03
In a study examining the factors that play a role in an older adult's transition to disability, intervening illnesses and injuries that led to hospitalization or activity restriction were associated with worsening functional ability, especially among those who were physically frail, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Thomas M. Gill, M.D., of the Yale University School of Medicine, New Haven, Conn., presented the findings of the study at a JAMA media briefing at the National Press Club.
Among older persons, disability in essential ...
2010-11-03
Use of a fall prevention tool kit, which included a fall risk assessment, patient-specific prevention plan, an educational handout and a poster for over the patient's hospital bed reduced the number of older patients with falls in hospitals, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Patricia C. Dykes, R.N., D.N.Sc., of Partners HealthCare System, Brigham and Women's Hospital and Harvard Medical School, Boston, presented the findings of the study at a JAMA media briefing at the National Press Club.
"Falls are a public health problem ...
2010-11-03
In a review of comprehensive primary care programs for older adults with multiple chronic conditions, authors identified three models that appear to have the greatest potential for improving quality of care and life for these patients, while reducing or not increasing the costs of their health care, according to an article in the November 3 issue of JAMA, a theme issue on aging.
Chad Boult, M.D., M.P.H., M.B.A., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, presented the findings of the study at a JAMA media briefing at the National Press Club.
"Older ...
LAST 30 PRESS RELEASES:
[Press-News.org] Einstein launches SuperAgers.com to spotlight aging research
Website focuses on genetic links to healthy aging
